Nextel Medical Corp (MAJI)
Nextel Medical Corp. is a clinical-stage biotechnology company focused on exploring the therapeutic potential of exosomes in oncology applications in the United States. The company is listed on OTC Markets under the ticker MAJI and its common stock trades on the OTC exchange. It was incorporated in 2010 and is based in Saint Petersburg, Florida. The company was previously known as Exousia Pro, Inc., and adopted its current name in April 2026.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Market Cap |
|---|---|---|---|---|---|---|---|
|
OTC-MAJI
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
September 25, 2026
|
416.431 K
|